In this issue, we have covered a couple of hot topics that are currently trending in the biotech and blockchain technology industries. We have highlighted Illumina’s Q2 results and provided some
insights about the company alongwith a quick run-through of the firm’s recent collaborations in China. Illumina reported a revenue of $830 million in Q2 which is a 25% increase compared to $662 million in the same quarter of 2017. Illumina’s biggest advantage over its competitors lies in its technology diversification.
We have also discussed about Walmart, who aims to venture into transportation and logistics markets through a methodology (recently filed for patent) by which the transaction data associated with appliances are stored in a ledger using blockchain technology. Read more on this report.